Pharmaceutical Companies Face New U.S. Tariffs Impact

Major pharmaceutical companies are bracing for a wave of new tariffs set to take effect next month, potentially altering pricing strategies and supply chains. These tariffs aim to impact both imported raw materials and finished products, putting significant pressure on an industry heavily reliant on international sourcing. Companies are actively adapting their supply chains, logistics plans, and pricing structures in anticipation of these economic shifts.